 |
|
|
 |
|
Ginseng, Flaxseed May Help Cancer Patients
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 | 3 After a follow-up of almost four years, researchers could find no statistically significant difference in survival between patients taking shark cartilage (14.4 months) and those receiving a placebo (15.6 months).
"This is the first large, rigorous, scientifically done clinical trial of shark cartilage," said study author Dr. Charles Lu, an associate professor in the department of thoracic, head and neck medical oncology at M.D. Anderson Cancer Center in Texas. "For the first time, oncologists will have something to discuss with their patients. When the patient asks whether he or she should spend his money on shark cartilage, the oncologist can at least say there has been one large trial funded by the National Cancer Institute and, unfortunately, it was negative."
The company has stopped development of the product.
Text Continues Below

More information
There's more on complementary and alternative cancer treatments at the U.S. National Cancer Institute.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 6/2/2007
|
 |

SOURCES: Charles Lu, M.D., associate professor, department of thoracic/head and neck medical oncology, M.D. Anderson Cancer Center, Houston; Richard Greenberg, M.D., chief of urologic oncology, Fox Chase Cancer Center, Philadelphia; Debra L. Barton, associate professor, oncology, Mayo Clinic, Rochester, Minn.; June 2, 2007, presentation, American Society of Clinical Oncology, Chicago
|